Brand check
Is Zincovit banned in India?
Last checked 19 September 2026
Zincovit is not banned in India as of 19 Sep 2026; no notification names the product, and the multivitamin batches that appear in CDSCO monthly alerts are batch-specific findings against the manufacturers listed.
- Classification
- No ban or recall found in official records
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- No Section 26A notification for Zincovit
- Latest action
- 21 August 2026
- Last checked
- 19 September 2026
Multivitamin and multimineral tablet pack. Photo: Multivitamins complete a to z 250 tablets.jpg by Mike1024 (Public domain). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.
CDSCO: Drug alerts (monthly NSQ / spurious lists)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Ban notification
- None
- Manufacturer
- Apex Laboratories
- Class-level alerts
- Multivitamin and vitamin B/C/D3 batches from various makers appear as NSQ in most monthly alerts (e.g. Dec 2025, Jul 2026)
- Note
- Multivitamins are regulated as drugs when sold with therapeutic claims; no FDC ban has targeted them
Where the claim comes from
Zincovit sold in vast quantities during the pandemic, and multivitamin batches from various small manufacturers appear in almost every CDSCO monthly alert as not of standard quality. Headlines such as 'vitamin tablets fail quality test' are read as being about the best-known brand. No alert we have seen names Zincovit.
Zincovit is Apex Laboratories' multivitamin-multimineral tablet and syrup, made famous by pandemic-era immunity advice. It is not banned in India.
No Section 26A notification names Zincovit or its ingredients, and multivitamins have not been the target of any of the FDC ban waves, which have concerned combinations of active drugs rather than vitamins and minerals. Nor have we found Zincovit in the CDSCO's monthly quality alerts for the 2024 to 2026 period we have reviewed.
The question comes from the alerts themselves. In almost every month, vitamin products from some manufacturer appear among the samples found not of standard quality, vitamin B complex, vitamin C, vitamin D3 and multivitamin tablets in 2024, multivitamins in the December 2025 alert, and vitamin A, D3 and B1 products from a firm named Crossasia Biotech in the July 2026 alert, which listed 280 NSQ samples in all. These are typically small manufacturers supplying government tenders, and the usual failure is that a tablet contains less of a vitamin than its label states. The news headline, "vitamin tablets fail quality test", does not name the maker, and readers substitute the brand they know.
A batch-level finding applies to the manufacturer and batch listed. Zincovit can be taken as before; if an alert ever names it, compare the batch on your pack. The more useful question for a doctor is whether a daily multivitamin is needed at all.
What this means for you
Zincovit is available as before
It is licensed and not the subject of any action.
Check the manufacturer on any alert
Multivitamin NSQ findings name a maker and a batch; unless both match your pack, the finding is about another product.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
No NSQ batch on record. No product matching this name appears in CDSCO or state-lab NSQ alerts from Jan 2019 to July 2026. Absence from the alerts is not proof of quality, check your batch number.
Official sources and primary records
- Business Standard: CDSCO flags 7 drugs as spurious, 167 fail quality tests in Dec 2025NewsBusiness Standard · 21 January 2026
- ETV Bharat: CDSCO flags 280 drug samples as NSQ or spurious in JulyNewsETV Bharat · 21 August 2026
- Business Standard: CDSCO flags 4 drugs as spurious and 48 as not of standard qualityNewsBusiness Standard · 24 October 2024
- Regulator